BiomimX Srl is a pioneering Contract Research Organisation (CRO) and a standout in the pharmaceutical industry, specialising in Organ on a Chip (OoC) technology. The company is dedicated to producing the next generation of clinically relevant in-vitro models for pharmaceutical drug discovery and testing. Its proprietary platform, uBeat®, integrates microfluidics, 3D cell culture, live human cells, and mechanical stimuli to create “Beating OoC” models. These systems are designed to recapitulate, with unprecedented precision and predictability, clinically relevant models that reflect human pathophysiology, making them suitable for drug safety and efficacy testing.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– In-vitro testing solutions
– Drug discovery and development support
– Customised experimental design and analysis
– Training and consultancy services

BiomimX Srl is at the forefront of innovative solutions for the pharmaceutical sector, contributing significantly to advancements in drug discovery and development. Interested parties are encouraged to find more information at biomimx.com.